“Anti-cancer activity of midostaurin in hormone refractory human prostate cancer DU145 cells”, Bangladesh J Pharmacol, vol. 11, no. 2, pp. 378–382, Mar. 2016, doi: 10.3329/bjp.v11i2.24954.